Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.
Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.
复制标题
DOI:
10.1016/j.jacc.2009.04.097
复制
发表时间:
2009-10-20
影响因子:
24
通讯作者:
Marban, Eduardo
中科院分区:
文献类型:
--
作者:
Terrovitis, John;Lautamaeki, Riikka;Bonios, Michael;Fox, James;Engles, James M.;Yu, Jianhua;Leppo, Michelle K.;Pomper, Martin G.;Wahl, Richard L.;Seidel, Jurgen;Tsui, Benjamin M.;Bengel, Frank M.;Abraham, M. Roselle;Marban, Eduardo
To quantify acute myocardial retention of cardiac-derived stem cells (CDCs) and evaluate different delivery methods using Positron Emission Tomography (PET). Success of stem cell transplantation for cardiac regeneration is partially limited by low retention/engraftment of the delivered cells. A clinically applicable method for accurate quantification of cell retention would enable optimization of cell delivery. CDCs derived from syngeneic, male Wistar Kyoto (WK) rats were labeled with 18FDG and injected intramyocardially into the ischemic region of female WK rats following permanent left coronary artery ligation. The effects of fibrin glue, bradycardia (adenosine) and cardiac arrest were examined. 18FDG PET was performed for quantification of cell retention. Quantitative PCR for the male-specific SRY gene was performed to validate the PET results. Myocardial retention of cells suspended in PBS 1 hr after delivery was 17.6±11.5% by PCR and 17.8±7.3% by PET. When CDCs were injected immediately following induction of cardiac arrest, retention was increased to 75.6±18.6%. Adenosine slowed the ventricular rate and doubled CDC retention (35.4±5.3%). A similar increase in CDC retention was observed following epicardial application of fibrin glue at the injection site (37.5±8.2%). PCR revealed a significant increase in 3 week cell engraftment in the fibrin glue animals (22.1±18.6% vs 5.3±3.1%, for fibrin glue and PBS respectively). In vivo PET permits accurate measurement of CDC retention early after intramyocardial delivery. Sealing injection sites with fibrin glue or lowering ventricular rate by adenosine may be clinically translatable methods for improving stem cell engraftment in a beating heart.
登录
查看更多内容
DOI:
10.1007/s00259-005-1898-5
发表时间:
2005-12-01
影响因子:
9.1
作者:
Bengel, Frank M.;Schachinger, Volker;Dimmeler, Stefanie
通讯作者:
Dimmeler, Stefanie
影响因子:
37.8
作者:
Cao, F;Lin, S;Wu, JC
通讯作者:
Wu, JC
影响因子:
37.8
作者:
Hofmann, M;Wollert, KC;Drexler, H
通讯作者:
Drexler, H
DOI:
10.1016/s1091-255x(98)80071-1
发表时间:
1998-07-01
期刊:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
影响因子:
--
作者:
Hayashi, M;Martinez, O M;Esquivel, C O
通讯作者:
Esquivel, C O
影响因子:
37.8
作者:
Kraitchman, DL;Tatsumi, M;Bulte, JWM
通讯作者:
Bulte, JWM